News & Events

Apr 20, 2022


ViaCyte to Participate in 2022 Advanced Technologies & Treatments for Diabetes Conference

Dr. Manasi Jaiman, newly appointed Chief Medical Officer, to discuss patient-reported outcomes associated with cell therapy in type 1 diabetes SAN DIEGO, Calif., April 20, 2022 – Manasi Sinha Jaiman, M.D., M.P.H., who was recently appointed Chief Medical Officer at ViaCyte, Inc., a clinical-stage cellular therapy company with an advanced stem cell platform that delivers […]

Read More

Sign up for updates

To have our press releases and major updates sent to you, please provide your name and email address.